STOCK TITAN

Vanguard disaggregates holdings; reports 0% in ASP Isotopes (ASPI)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

ASP Isotopes Inc: An amendment to a Schedule 13G/A states that The Vanguard Group reports 0% beneficial ownership of the issuer's common stock as of the amendment filing. The filing explains an internal realignment of Vanguard subsidiaries on January 12, 2026 that led to disaggregated reporting; Vanguard lists 0 shares and no voting or dispositive power.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial stake after internal realignment.

The amendment records 0 shares and 0% ownership, citing an internal reorganization on January 12, 2026 and separate reporting by certain subsidiaries in reliance on SEC Release No. 34-39538.

This filing is administrative: subsequent disclosures by Vanguard-affiliated entities could show holdings. Future filings by those entities would clarify any indirect positions.

The amendment documents compliance with SEC disaggregation guidance.

The text cites SEC Release No. 34-39538 as the basis for separate reporting by Vanguard subsidiaries and states that Vanguard "no longer has, or is deemed to have, beneficial ownership" of securities held by those units.

Watch for additional Schedule 13G/A or Form 13F entries from Vanguard subsidiaries for complete institutional ownership transparency.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026

FAQ

What does The Vanguard Group report for ASP Isotopes (ASPI)?

The Vanguard Group reports 0 shares and 0% beneficial ownership in ASP Isotopes. The filing states Vanguard has no sole or shared voting or dispositive power over the common stock.

Why does Vanguard say it reports separately for some subsidiaries?

Vanguard cites SEC Release No. 34-39538 and an internal realignment on January 12, 2026. Certain subsidiaries will report holdings separately and are no longer deemed beneficially owned by The Vanguard Group.

Does this amendment show any voting control by Vanguard over ASPI shares?

No. The amendment lists 0 shares for sole voting power and 0 for shared voting power, indicating Vanguard reports no voting control in this filing.

Who signed the Schedule 13G/A amendment for Vanguard?

The filing is signed by Ashley Grim, titled Head of Global Fund Administration, with a signature date of 03/26/2026 on the amendment.
ASP Isotopes

NASDAQ:ASPI

View ASPI Stock Overview

ASPI Rankings

ASPI Latest News

ASPI Latest SEC Filings

ASPI Stock Data

630.56M
107.58M
Chemicals
Miscellaneous Chemical Products
Link
United States
WASHINGTON